United States
2017
Entrant Company
Category
Client's Name
Sub-Category
Dr. Janet Woodcock, Director of FDA’s Center for Drug Evaluation and Research, delves into how and why CDER’s Biomarker Qualification Program supports the development of biomarkers by different groups and the benefits of the qualification process for regulatory decision-making and public adoption of new biomarkers.
Credits
Entrant Company
American Family Mutual Insurance Company, S.I.
Category
Copy or Writing